It slices, it dices, it’s faster than a speeding bullet. Yes, we have heard this many times before, so don’t get too excited yet. On February 15, 2017, Loughborough, UK. Nemaura Medical Inc., a medical device company developing a non-invasive, needle-free, pain-free, daily-disposable, and cost effective wireless CGM (Continuous Glucose Monitoring) patch known as sugarBEAT®, announced that its multicenter open label clinical study has been selected for poster exhibit at the Advanced Technologies and Treatments for Diabetes (ATTD) Conference in Paris.
So, how does it work? Passing a mild, non-perceptible electric current across the skin, the BEAT™ technology draws a small amount of selected molecules, such as glucose, into a patch placed on the skin. These molecules are drawn out of the interstitial fluid, which naturally sits just below the top layer of the skin. Via a sensor, the patient-friendly patch measures the amount of molecule present, converting it into a meaningful concentration value for clinical diagnosis or preliminary guidance for self-treatment and then shows up on your smartphone. The firm expects to release the system toward the end of this year in Europe.